EYEN - アイノビア (Eyenovia Inc.)

EYENのニュース

   Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2021 Results - Earnings Call Transcript  2022/03/29 02:13:03 Seeking Alpha
   Eyenovia GAAP EPS of $0.10 beats by $0.32, revenue of $10M  2022/03/28 20:13:09 Seeking Alpha
Eyenovia press release (EYEN): Q4 GAAP EPS of $0.10 beats by $0.32.Revenue of $10M (+400.0% Y/Y).As of December 31, 2021, the Company’s cash and cash equivalents were approximately…
   Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results  2022/03/28 20:05:00 GlobeNewswire
Successfully completed Type A meeting with FDA and anticipates MydCombi™ NDA resubmission in Q3 2022
   Eyenovia Raises 15M Via Equity To Advance MydCombi Program  2022/03/04 14:07:56 Benzinga
Eyenovia Inc (NASDAQ: EYEN ) has entered into a Securities Purchase Agreement with Armistice Capital Master Fund Ltd for gross proceeds of $15 million . The offering includes 3 million shares, pre-funded warrants to purchase up to 1.87 million shares, and common warrants to purchase up to 4.87 million shares. The aggregate offering price for each share of … Full story available on Benzinga.com
   Eyenovia receives $15M institutional capital investment from Armistice Capital  2022/03/04 12:44:29 Seeking Alpha
Eyenovia (EYEN) trades 2.3% down premarket after it entered into a securities purchase agreement with Armistice Capital Master Fund in an offering of 3M shares of its common…
   Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation  2021/06/02 10:10:14 Seeking Alpha
   Chasing Allergan, Eyenovia hits endpoint in vision phase 3  2021/05/28 07:46:30 FiercePharma
Chasing Allergan, Eyenovia hits endpoint in vision phase 3 ntaylor Fri, 05/28/2021 - 03:46
   Eyenovia (EYEN) Gets a Buy Rating from Northland Securities  2021/05/26 14:00:17 Smarter Analyst
Northland Securities analyst Tim Chiang maintained a Buy rating on Eyenovia (EYEN) yesterday and set a price target of $12.00. The post Eyenovia (EYEN) Gets a Buy Rating from Northland Securities appeared first on Smarter Analyst .
   Eyenovia Stock Shoots Higher on Positive MicroLine Data in Late-Stage Presbyopia Study  2021/05/25 15:18:54 Benzinga
Eyenovia Inc (NASDAQ: EYEN ) has announced topline data from its VISION-1 Phase 3 study evaluating MicroLine, for the temporary improvement of near vision in adults with presbyopia. The results will be presented at a future ophthalmic-focused medical meeting. The study met its primary endpoint with a statistically significant proportion of subjects treated with MicroLine showing Full story available on Benzinga.com
   Stock Alert: Eyenovia Up 10% On Positive Late-stage Study Results Of Its MicroLine  2021/05/25 14:12:32 RTT News
Shares of Eyenovia, Inc. (EYEN) are rising more than 10% Tuesday morning after the company announced positive top line results from the late-stage study of MicroLine for the treatment of Presbyopia.
   Eyenovia: Recent MicroLine Data, October MydCombi PDUFA Date Bode Well For Value Creation  2021/06/02 10:10:14 Seeking Alpha

calendar